Filing Details

Accession Number:
0000899243-16-027346
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-16 19:00:41
Reporting Period:
2016-08-12
Filing Date:
2016-08-16
Accepted Time:
2016-08-16 19:00:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1285819 Omeros Corp OMER Pharmaceutical Preparations (2834) 911663741
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472158 J. Thomas Cable 201 Elliott Avenue West
Seattle WA 98119
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-08-12 3,000 $11.52 46,067 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2016, at which time the trading schedule, including sale periods and the number of shares to be sold, was established in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This Rule 10b5-1 plan provides for fixed sales of a total of 9,000 shares over a one-year period beginning on August 12, 2016 and ending May 20, 2017, with sale periods commencing approximately every four months. This sale of 3,000 shares is the result of the first trade pursuant to this trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $11.41 to $11.56; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.